Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1

Status

Completed 6Unknown 3Recruiting 2Available 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Prostatic Neoplasms 1Liver Diseases 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 290Drug Therapy 276Bevacizumab 248apatinib 247camrelizumab 219Etoposide 201Irinotecan 182Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × fluorocholine × Clear all
NCT05622162 2024-05-22

MIP7

ITEL Telecomunicazioni Srl

Phase 3 Unknown
106 enrolled
Genitourinary

Prostatic Neoplasms

NCT01956409 2016-02-04

Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer Diagnosis

National Taiwan University Hospital

Phase 4 Unknown
80 enrolled
Breast

Breast Neoplasms

NCT02074202 2014-02-28

To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma

National Taiwan University Hospital

Phase 3 Unknown
150 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡